<div id="readability-page-1">11:27 AM EDT, 05/19/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.3% to 1,824.16 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and internet advertising company Criteo ( CRTO ) , which advanced 5.3% and 3.6% respectively. They were followed by biopharmaceutical company argenx (ARGX) and petroleum refiner Equinor ( EQNR ) , which rose 2.1% and 1.3% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and telecommunications company Nokia ( NOK ) , which dropped 3.5% and 2.7% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which were off 2.6% and 1.6% respectively.The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which were up 4.9% and 3.5% respectively. They were followed bybiopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and medical device company Smith &amp; Nephew ( SNN ) , which were up 3.1% and 2.6% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) , which fell 8%, followed by mining company BHP Group ( BHP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 3% and 0.6% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

SQNS

European equities traded in the US as American depositary receipts fell 0.3% to 1,824.16 on the S&P Europe Select ADR Index. Notable gainers included SAP (+5.3%) and Criteo (+3.6%), while Sequans Communications (-3.5%) and Nokia (-2.7%) were among the decliners. In the UK, Akari Therapeutics (+4.9%) and NuCana (+3.5%) rose, while Autolus Therapeutics (-8%) led the declines.

fidelity

European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading